Bridgeway Capital Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.8K | Hold |
25,000
| – | – | ﹤0.01% | 1125 |
|
|
2025
Q1 | $108K | Buy |
+25,000
| New | +$108K | ﹤0.01% | 1026 |
|
|
2024
Q1 | – | Sell |
-9,138
| Closed | -$146K | – | 1384 |
|
|
2023
Q4 | $146K | Hold |
9,138
| – | – | ﹤0.01% | 1189 |
|
|
2023
Q3 | $696K | Buy |
9,138
+3,388
| +59% | +$258K | 0.02% | 803 |
|
|
2023
Q2 | $377K | Buy |
5,750
+3,250
| +130% | +$213K | 0.01% | 985 |
|
|
2023
Q1 | $150K | Sell |
2,500
-4,500
| -64% | -$269K | ﹤0.01% | 1161 |
|
|
2022
Q4 | $163K | Buy |
7,000
+2,500
| +56% | +$58.3K | ﹤0.01% | 1136 |
|
|
2022
Q3 | $151K | Sell |
4,500
-2,500
| -36% | -$83.9K | ﹤0.01% | 1194 |
|
|
2022
Q2 | $186K | Sell |
7,000
-3,000
| -30% | -$79.7K | ﹤0.01% | 1106 |
|
|
2022
Q1 | $294K | Hold |
10,000
| – | – | 0.01% | 1086 |
|
|
2021
Q4 | $855K | Hold |
10,000
| – | – | 0.02% | 822 |
|
|
2021
Q3 | $745K | Buy |
+10,000
| New | +$745K | 0.01% | 915 |
|